Lacerta Bio is a business development consultancy specializing in identifying, assessing, negotiating, and closing licensing and partnership opportunities for the pharmaceutical, biotechnology, and drug delivery industries.
We also work with and support internal business development teams with market research, competitive intelligence, financial modeling, and other support services.
If you need assistance finding or assessing business development and/or partnership opportunities, contact us at firstname.lastname@example.org.
This morning we learned that Sanofi is the winner in the “Where on Earth is the Partner for Afrezza?” sweepstakes.
We’ll defer to the many news outlets for the details. But one interesting take on the deal is from TheStreet.com. A few good points were raised:
It will be really interesting to see some of the sales number when they start coming out next year.
For a more detailed analysis of the rationale for this deal from a Sanofi perspective, check out this article on seekingalpha.com
Yes, and it might be worth it. Yesterday, Daiichi Sankyo announced an incredible $650 million deal with Florida-based Charleston Laboratories for the development and commercialization of a family of fixed dose combination products. The lead candidate, CL-108, is a fixed dose combination of promethazine, hydrocodone, and acetaminophen. The deal was signed on the back of Read More »
Source: Nature Biotechnology, 32, 617–619, (2014), Published online 08 July 2014 Our good friends at Venture Valuation published an interesting study in the July issue of Nature Biotechnology. In the study, the authors address an interesting question, namely, do small-to-medium sized enterprises (SMEs) receive more lucrative deals from Big Pharma compared to other SMEs? Read More »
Do you know which are the top branded drug products in India? We didn’t until we found this handy chart and article. We took their IMS data a step further by compiling a new table that includes generic names, companies, and sales in US dollars. A few quick observations: Cough/cold and antibiotics, both short-term Read More »